arjunolic acid has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aamir, K; Afrin, MR; Arya, A; Hossain, CF; Jusuf, PR; Khan, HU; Sethi, G; Waheed, I | 1 |
Aamir, K; Afrin, MR; Arya, A; Hossain, CF; Jusuf, PR; Sarker, SD; Sethi, G | 1 |
2 other study(ies) available for arjunolic acid and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide induced type 2 diabetic rats.
Topics: Animals; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Inflammation; Male; Rats; Rats, Sprague-Dawley; Terminalia; Triterpenes | 2022 |
Arjunolic acid modulate pancreatic dysfunction by ameliorating pattern recognition receptor and canonical Wnt pathway activation in type 2 diabetic rats.
Topics: Animals; beta Catenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Myeloid Differentiation Factor 88; NF-kappa B; Pancreas; Rats; Toll-Like Receptor 4; Wnt Signaling Pathway | 2023 |